ModivCare Inc. (MODV)
NASDAQ: MODV · IEX Real-Time Price · USD
27.39
+0.33 (1.22%)
Jul 2, 2024, 4:00 PM EDT - Market closed
ModivCare Revenue
ModivCare had revenue of $2.78B in the twelve months ending March 31, 2024, with 6.78% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $684.45M with 3.12% year-over-year growth. In the year 2023, ModivCare had annual revenue of $2.76B with 9.73% growth.
Revenue (ttm)
$2.78B
Revenue Growth
+6.78%
P/S Ratio
0.14
Revenue / Employee
$130,985
Employees
21,200
Market Cap
389.24M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.76B | 244.46M | 9.73% |
Dec 31, 2022 | 2.51B | 509.41M | 25.44% |
Dec 31, 2021 | 2.00B | 633.66M | 46.30% |
Dec 31, 2020 | 1.37B | -141.27M | -9.36% |
Dec 31, 2019 | 1.51B | 124.98M | 9.02% |
Dec 31, 2018 | 1.38B | 66.75M | 5.06% |
Dec 31, 2017 | 1.32B | 84.38M | 6.84% |
Dec 31, 2016 | 1.23B | -244.17M | -16.52% |
Dec 31, 2015 | 1.48B | 385.13M | 35.24% |
Dec 31, 2014 | 1.09B | 294.11M | 36.82% |
Dec 31, 2013 | 798.77M | -307.12M | -27.77% |
Dec 31, 2012 | 1.11B | 162.91M | 17.28% |
Dec 31, 2011 | 942.98M | 63.28M | 7.19% |
Dec 31, 2010 | 879.70M | 78.68M | 9.82% |
Dec 31, 2009 | 801.01M | 109.34M | 15.81% |
Dec 31, 2008 | 691.67M | 406.50M | 142.55% |
Dec 31, 2007 | 285.17M | 93.31M | 48.63% |
Dec 31, 2006 | 191.86M | 46.15M | 31.67% |
Dec 31, 2005 | 145.71M | 48.74M | 50.27% |
Dec 31, 2004 | 96.97M | 37.69M | 63.58% |
Dec 31, 2003 | 59.28M | 26.45M | 80.57% |
Jun 30, 2002 | 32.83M | 8.16M | 33.06% |
Jun 30, 2001 | 24.67M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Emergent BioSolutions | 1.19B |
Bioventus | 522.74M |
Organogenesis Holdings | 435.47M |
Health Catalyst | 296.79M |
Pacific Biosciences of California | 200.43M |
Anika Therapeutics | 169.26M |
Fate Therapeutics | 6.48M |
Lyell Immunopharma | 68.00K |
MODV News
- 5 weeks ago - Modivcare Releases 2023 Sustainability Report Highlighting Responsible Business Practices and Advancements in Environmental Management - Business Wire
- 5 weeks ago - Modivcare to Present at Upcoming Investor Conferences - Business Wire
- 6 weeks ago - Modivcare Unveils Integration Hub: Revolutionizing Access to NEMT Benefits - Business Wire
- 7 weeks ago - Genesys Recognizes Modivcare as Winner of EX Mobilizer Award - Business Wire
- 2 months ago - Modivcare Reports First Quarter 2024 Financial Results; Maintains Guidance - Business Wire
- 2 months ago - Modivcare to Report First Quarter 2024 Financial Results - Business Wire
- 3 months ago - GE Vernova and Solventum Set to Join S&P 500; Dentsply Sirona to Join S&P MidCap 400; Others to Join S&P SmallCap 600 - PRNewsWire
- 4 months ago - Modivcare's NEMT Mobility App for Members Sets Best-in-Class Rankings and User Adoption, Pioneers New Advancements - Business Wire